Grants and Contracts Details
Description
Specific Aims
Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) are important respiratory viruses which
cause significant morbidity and mortality, particularly in pediatric, elderly and immunocompromised patients.
Newer, more sensitive molecular techniques show that patients with respiratory infections are frequently infected
with more than one viral pathogen. In the case of RSV and HMPV co-infections, some studies have suggested no
impact or limited impact while other research strongly indicates that RSV-HMPV co-infection has a deleterious
effect on the course of disease and severity of symptoms. Thus, the impact of RSV/HMPV co-infections remains
a critical area for continued study, but relatively little is known about the mechanisms by which co-infections may
affect the steps of the viral lifecycle. Viral interference through triggering of innate immunity and competition for
cellular resources have been studied for their roles in co-infection, and very recent work suggests that hybrid viral
particles. Our preliminary studies of HMPV/RSV co-infection demonstrate that IBs in co-infected cells can
contain both RSV and HMPV genomes, indicating a shared replication compartment. Our overall hypothesis is
that HMPV/RSV co-infection affects both virus replication and virus spread. To test this, we will pursue two
Specific Aims, using a range of experimental approaches. First, we will dissect the effect of HMPV/RSV co-
infection on IB formation, dynamics and viral replication, including careful analysis of IBs over the course of
infection and analysis of viral transcription and replication at the global and single cell level. Second, we will
determine the effect of HMPV/RSV co-infection on potential hybrid virus particle formation and multi-virus cell-
cell spread. These important experiments may elucidate new molecular consequences of viral co-infection,
providing insight that may inform studies of additional respiratory viruses.
Status | Active |
---|---|
Effective start/end date | 8/11/23 → 7/31/25 |
Funding
- National Institute of Allergy and Infectious Diseases: $413,248.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.